Since the first description of the community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain USA300 [1] in the 1990s, this pathogen has emerged worldwide [2]. Within a decade, USA300 has become the most prevalent cause of community-acquired S. aureus infections in many settings in the United States [3]. Originally causing infections mainly in individuals without recent healthcare exposure, USA300 is increasingly causing hospital-acquired infections. There is, therefore, an urgent need for infection control measures. Although person-to-person transmission in the community must be the driving force of this epidemic [4], transmission dynamics and risk factors for colonization are still not well understood [5]. The study...
Staphylococcus aureus is a worldwide leading cause of skin and soft tissue, bone and joint, and bloo...
Background. The USA300 methicillin resistant Staphylococcus aureus (MRSA) genetic background has rap...
(See the article by Peyrani et al, on pages 766–71.) Background. Though USA300 community-onset methi...
Since the first description of the com-munity-associated methicillin-resistant Staphylococcus aureus...
BACKGROUND: In 2004, an outbreak of the USA300 strain of methicillin-resistant Staphylococcus aureus...
The frequency of methicillin-resistant Staphylococcus aureus (MRSA) infections continues to grow in ...
Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methi...
Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methi...
BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections ar...
The bacterium Staphylococcus aureus is a notorious pathogen that causes dangerous and difficult-to-t...
Background. Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) plays a key role in...
AbstractThe epidemic of USA300-0114 methicillin-resistant Staphylococcus aureus (MRSA) in the USA ha...
Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methi...
Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is able to persist not only in hospitals...
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen that has historically b...
Staphylococcus aureus is a worldwide leading cause of skin and soft tissue, bone and joint, and bloo...
Background. The USA300 methicillin resistant Staphylococcus aureus (MRSA) genetic background has rap...
(See the article by Peyrani et al, on pages 766–71.) Background. Though USA300 community-onset methi...
Since the first description of the com-munity-associated methicillin-resistant Staphylococcus aureus...
BACKGROUND: In 2004, an outbreak of the USA300 strain of methicillin-resistant Staphylococcus aureus...
The frequency of methicillin-resistant Staphylococcus aureus (MRSA) infections continues to grow in ...
Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methi...
Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methi...
BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections ar...
The bacterium Staphylococcus aureus is a notorious pathogen that causes dangerous and difficult-to-t...
Background. Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) plays a key role in...
AbstractThe epidemic of USA300-0114 methicillin-resistant Staphylococcus aureus (MRSA) in the USA ha...
Staphylococcus aureus is the most frequent cause of skin and soft tissue infections in humans. Methi...
Abstract Methicillin-resistant Staphylococcus aureus (MRSA) is able to persist not only in hospitals...
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen that has historically b...
Staphylococcus aureus is a worldwide leading cause of skin and soft tissue, bone and joint, and bloo...
Background. The USA300 methicillin resistant Staphylococcus aureus (MRSA) genetic background has rap...
(See the article by Peyrani et al, on pages 766–71.) Background. Though USA300 community-onset methi...